Edwards evoque transcatheter tricuspid valve replacement system receives ce mark

Irvine, calif. , oct. 19, 2023 /prnewswire/ -- edwards lifesciences corporation (nyse: ew) today announced the company's evoque tricuspid valve replacement system received ce mark for the transcatheter treatment of eligible patients with tricuspid regurgitation (tr).
EW Ratings Summary
EW Quant Ranking